Zhitong Finance App learned that sustainable product manufacturer Med-X submitted documents to the US Securities and Exchange Commission (SEC) on Friday to register its shares and complete a direct listing on the NASDAQ. The company plans to be listed on the NASDAQ under the stock code “MXRX”. As this direct listing does not involve underwriting commitments, the deal has no underwriters; Maxim Group will act as financial advisor.

The common shares of Med-X listed this time will be sold by existing shareholders, and the company will not raise new capital through this listing. Registered shareholders can sell up to 13.1 million common shares, which is equivalent to all of the company's issued shares.

Med-X develops and sells natural “green” products through its Nature-Cide, Thermal-Aid, and Malibu Brands divisions. Nature-Cide produces the lowest risk plant-derived insecticides and repellents for professional pest control, hospitality, agriculture and other fields; Thermal-Aid produces natural hot and cold pain relief products. Both types of products are sold through national distributors and e-commerce platforms. In the six-month period ending June 2025, Nature-Cide accounted for 54% of the company's revenue, and Thermal-Aid accounted for 44%. According to the data, the company's revenue for the 12 months ending June 30, 2026 was US$2 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.